InvestorsHub Logo
Followers 44
Posts 5660
Boards Moderated 0
Alias Born 10/28/2009

Re: DR5 post# 4619

Friday, 03/20/2020 5:50:37 PM

Friday, March 20, 2020 5:50:37 PM

Post# of 13647
Just my opinion but I read this to mean the company was delayed but has started the review with FDA again?....today announced that it is proceeding with its Premarket Approval (PMA) application for Class III approval to the FDA for HemoStyp®. Doesn't say continuing but proceeding and maybe its wishful thinking? Good day regardless .74 beats .57
$10+